Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Micro Therapeutics Inc.

Division of Medtronic PLC
www.microtherapeutics.com

Latest From Micro Therapeutics Inc.

Appeals Court Rejects False Claims Approach To FDA Off-Label Cases

A ruling from the First Circuit suggests that plaintiffs can’t prove manufacturers violated the False Claims Act by suggesting FDA submissions were fraudulent, if FDA itself hasn’t taken any action against the manufacturer.

Legal Issues Government Payers

The Neurovascular Market Tilts Toward A Tipping Point

Acute ischemic stroke used to be a device category that promised a slow but certain death for start-ups. But there's lots of life in the market, as evidenced by a recent wave of consolidation. Meanwhile, hemorrhagic stroke companies have been perfecting the treatment of cerebral aneurysms.

Intersect Partners: Does the Incubator Model Still Work?

A decade ago, during the device industry's first financing crisis, medical device incubators played a crucial role in keeping small start-ups viable. But incubators themselves soon ran into problems, most notably in finding a sustainable financing model for themselves. California-based Intersect Partners has been one of the most successful incubators but it, too, needed to find a new model to make incubation viable.
Medical Device Business Strategies

Striking Out Against Stroke

Predicting, preventing, and treating stroke has always been challenging for drug and device developers. The sheer number of potential patients and the current scarcity of safe and effective treatment options make this one of the most intriguing markets. Innovation in the device arena continues at a slow but steady pace, and clinicians and patients are beginning to reap the benefits of recent advances.
Medical Device
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register